7 The role of prostaglandins in obstetrical disorders

Bailliere's Clinical Obstetrics and Gynaecology

Volumn 6, Issue 4, 1992, Pages 809-827

  Ylikorkala, Olavi ^a   Viinikka, Lasse ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; PROSTACYCLIN; PROSTAGLANDIN; THROMBOXANE A2;

ALCOHOL ABUSE; BACTERIAL INFECTION; CHILDBIRTH; FEMALE; FETUS BLOOD; HUMAN; HYDRAMNIOS; INTRAUTERINE GROWTH RETARDATION; OBSTETRICS; OLIGOHYDRAMNIOS; PHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PROLONGED PREGNANCY; PROSTAGLANDIN SYNTHESIS; RECURRENT ABORTION; REVIEW; SMOKING; SMOOTH MUSCLE FIBER; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERUS CONTRACTION;

ABORTION, HABITUAL; ALCOHOL DRINKING; EPOPROSTENOL; FEMALE; FETAL GROWTH RETARDATION; HUMAN; LABOR, PREMATURE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROSTAGLANDINS; SMOKING; THROMBOXANE A2; THROMBOXANE B2;

EID: 0027075032     PISSN: 09503552     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3552(05)80190-7     Document Type: Article

References (131)

1. Formal risk scoring during pregnancy
2. On the etiopathogenesis and therapy of Down syndrome
3. Intra-amniotic infection in patients with intact membranes and preterm labour
4. Post-term pregnancy: magnitude of the problem
5. Reduced serum inhibition of platelet-activating factor in pre-eclampsia
6. The effects of lipoxygenase metabolites of arachidonic acid on human myometrial contractility
7. Preterm labor: stimulation of arachidonic acid metabolism in human amnion cells by bacterial products
8. The safety and efficacy of tocolytic agents for the treatment of preterm labour
9. Prostacyclin activity in amniotic fluid in preeclampsia
10. Effect of eicosapentaenoic and docosahexanoic acids on blood pressure in hypertension
11. Essential fatty acids and pregnancy hypertension
12. Reduced prostacyclin production by cultured endothelial cells from umbilical arteries of babies born to women who smoke
13. Maternal vascular prostacyclin activity in preeclampsia
14. Treatment of polyhydramnios with prostaglandin synthetase inhibitor (indomethacin)
15. Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors
16. ‘Lupus’ anticoagulant and thrombosis—possible role in inhibition of prostacyclin formation
17. Biomolecular process in the initiation of parturition decidual activation
18. Monitoring the progress of labour
19. DIMINISHED PROSTACYCLIN FORMATION IN UMBILICAL ARTERIES OF BABIES BORN TO WOMEN WHO SMOKE
20. Prolonged maternal indomethacin therapy associated with oligohydramnios. Case reports
21. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents
22. Reduced prostacyclin production in pre-eclampsia
23. Pre-eclampsia and prostaglandins
24. Low dose aspirin in pregnancy
25. The effects of indomethacin and a β-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor. A randomized double blind study
26. Arachidonic acid metabolism in human placenta
27. Effect of prostaglandin synthetase inhibitors on the pressor response to angiotensin II in human pregnancy
28. Treatment of pregnancy hypertension with prostacyclin
29. Eicosanoids in the pathogenesis of preeclampsia
30. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension
31. Increased thromboxane in normal pregnancy is mainly derived from platelets
32. 2 synthesis in pregnancy-induced hypertension
33. Preeclampsia: a review of the role of prostaglandins
34. Endocrinology of human parturition: a review
35. Oxytocin receptors and human parturition: a dual role for oxytocin in the irritation of labor
36. Plasma levels of oxytocin and 13,14-dihydro-15-keto-prostaglandin F2α in preterm labor and the effect of ethanol and ritodrine
37. Independent association of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome
38. A Medical Papyrus from Egypt
39. Lupus anticoagulant and anticardiolipid antibodies in pregnancy. A review. In Immunochemistry and clinical implications. II Diagnosis and management
40. Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour
41. Oligohydramnios, meconium and perinatal death concurrent with indomethacin treatment in human pregnancy
42. 2) synthesis in human, rabbit and rat vascular tissue
43. Decreased prostacyclin production by placental cells in culture from pregnancies complicated by fetal growth retardation
44. Failure of exogenous prostacyclin to change placental and fetal blood flow in preeclampsia
45. Ritodrine infusion during late pregnancy; effects on fetal and placental blood flow, prostacyclin and thromboxane
46. Preterm labour
47. A comparison of two decidual cell populations by immunocytochemistry and prostaglandin production
48. Fetal urine output in hydramnio
49. Indomethacin therapy in the treatment of symptomatic polyhydramnios
50. Effect of acute ethanol intake on thromboxane and prostacyclin in human
51. A randomized double-dummy comparison between indomethacin and nylidrin in threatened preterm labor
52. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin
53. Effect of bacterial products on prostaglandin E production by amnion cells
54. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour
55. Prostacyclin and preeclampsia
56. The role of the fetus in the formation of amniotic fluid
57. Endothelin—a potent constrictor of small myometrial arteries of term pregnant women
58. Preeclampsia: pathophysiology, diagnosis and management
59. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders
60. Antiphospholipid antibody syndrome and recurrent fetal loss
61. Relation between umbilical prostacyclin production and blood-flow in the fetus
62. 2 production but normal prostacyclin by placenta in hypertensive pregnancies
63. Evidence that prostacyclin deficiency is a specific feature in preeclampsia
64. Decreased prostacyclin production in Down's syndrome
65. Placental thromboxane and prostacyclin production in the regulation of placental blood flow
66. 2 during labour
67. Maternal indomethacin therapy in the treatment of polyhydramnios
68. Relationship of vaginal bactobacillus species, cervical chlamydia trachomatis, and bacterial vaginosis to preterm birth
69. Potential role of endothelin-I in normal and hypertensive pregnancies
70. Pathways of arachidonic acid metabolism with specific application to the fetus and mother
71. Concentration of the prostacyclin metabolite 6-keto-prostaglandin F1α in amniotic fluid during late pregnancy and labour
72. Actions of endothelin-I on prostaglandin production by gestational tissues
73. Indomethacin in the Treatment of Premature Labor
74. Placental transfer of indomethacin in the human pregnancy
75. Nitric oxide: physiology, pathophysiology and pharmacology
76. Mitogenic activity is increased in the sera of preeclamptic women before delivery
77. Endothelin-I-induced vasoconstriction is not mediated by thromboxane release and action in the human fetal—placental circulation
78. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation
79. Cigarette smoking inhibits prostacyclin formation
80. Prostanoid excretion in human term and preterm gestation
81. Intravenous immunoglobulin treatment for recurrent abortions caused antiphospholipid antibodies
82. Leukotrienes in human umbilical plasma at birth
83. Prostaglandin synthesis inhibitors block alcoholinduced fetal hypoplasia
84. Measurement of fetal urine production in normal pregnancy by real time ultrasonography
85. Aspirin reduces alcohol-induced prenatal mortality and malformations in mice
86. Reduced umbilical and placental vascular prostacyclin and severe pre-eclampsia
87. Preeclampsia: an endothelial cell disorder
88. Infection and Preterm Labor
89. Arachidonate lipoxygenase metabolites in amniotic fluid of women with intra-amniotic infection and preterm labor
90. Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor
91. 2 (PGEM-II) in preterm labor
92. Amniotic fluid arachidonic lipoxygenase metabolites in preterm labor
93. Neutrofil attractant/activating peptide-1/interleukin-8 in term and preterm parturition
94. Systemic administration of interleukin-1 induces preterm parturition in mice
95. Endothelin-1,2 levels are increased in the amniotic fluid of women with preterm labor and microbial invasion of the amniotic cavity
96. Preeclampsia: Platelets and antiplatelet therapy
97. Preeclampsia: Platelets and antiplatelet therapy
98. Placental pathology in spontaneous miscarriage
99. Lipoxygenase activity in human uterine and intrauterine tissues: new prospects for control of prostacyclin production in pre-eclampsia
100. Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infection
101. A comparison of plasma prostaglandin levels in term and preterm labor
102. Anticardiolipin antibody-positive serum enhances endothelial cell platelet-activating factor production
103. Prostacyclin in pregnancy
104. Recurrent miscarriage II. Clinical associations, causes and management
105. Effect of nicotine on production of prostacyclin in human umbilical artery
106. Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndrome
107. 2 on the fetal and maternal sides of intact fetal membranes
108. 2 production but has no effect on lung prostacyclin synthesis in humans
109. Effects of smoking and nicotine on human prostacyclin and thromboxane production in vivo and in vitro
110. Treatment of preeclampsia with prostaglandin A1
111. Management of severe preeclampsia detected in early labor by prostaglandin A1 or dihydralazine infusions
112. Thromboxane dominance and prostacyclin deficiency in habitual abortion
113. Inactivation of vascular prostacyclin synthetase by platelet lipoxygenase products
114. Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth
115. Physiology of low-dose aspirin therapy for the prevention of preeclampsia
116. Increased placental progesterone may cause decreased placental prostacyclin production in preeclampsia
117. Prostaglandin F metabolite concentration as a prognostic factor in preterm labor
118. 2 have potent and differential actions on human uterine contractility
119. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension
120. Prostacyclin and thromboxane in gynecology and obstetrics
121. 2 in pregnancy and puerperium
122. Amniotic fluid prostacyclin and thromboxane in normal preeclamptic, and some other complicated pregnancies
123. Prostacyclin increases during human parturition
124. Production of prostacyclin and thromboxane during cesarean section
125. Maternal prostacyclin, thromboxane, and placental blood flow
126. Maternal thromboxane, prostacyclin and umbilical blood flow in human
127. Effect of nicotine on fetal prostacyclin and thromboxane in humans
128. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants
129. Vaginal and abdominal delivery increases maternal urinary 6-keto-prostaglandin F1α excretion
130. Effect of ethanol on thromboxane and prostacyclin synthesis by fetal platelets and umbilical artery
131. Urinary prostacyclin and thromboxane metabolites in drinking women and their infants: relation to the fetal alcohol effects